Sintx Technologies (NASDAQ:SINT – Get Free Report) and Terumo (OTCMKTS:TRUMY – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.
Dividends
Sintx Technologies pays an annual dividend of $0.60 per share and has a dividend yield of 44.6%. Terumo pays an annual dividend of $0.06 per share and has a dividend yield of 0.4%. Sintx Technologies pays out -35.5% of its earnings in the form of a dividend. Terumo pays out 12.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Sintx Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.
Valuation and Earnings
This table compares Sintx Technologies and Terumo”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Sintx Technologies | $3.02 million | 3.36 | -$10.36 million | ($1.69) | -0.80 |
| Terumo | $7.52 billion | 2.95 | $897.03 million | $0.48 | 31.35 |
Terumo has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Terumo, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and price targets for Sintx Technologies and Terumo, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
| Terumo | 0 | 0 | 0 | 2 | 4.00 |
Sintx Technologies currently has a consensus price target of $9.50, suggesting a potential upside of 606.32%. Given Sintx Technologies’ higher possible upside, equities research analysts plainly believe Sintx Technologies is more favorable than Terumo.
Insider & Institutional Ownership
18.4% of Sintx Technologies shares are held by institutional investors. 8.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Sintx Technologies and Terumo’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Sintx Technologies | -281.91% | -309.86% | -101.90% |
| Terumo | 9.31% | 7.03% | 4.83% |
Summary
Terumo beats Sintx Technologies on 9 of the 16 factors compared between the two stocks.
About Sintx Technologies
SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.
About Terumo
Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
